Allergy Therapeutics PLC Grant of Options under Long Term Incentive Plan (9885G)
November 25 2015 - 1:07PM
UK Regulatory
TIDMAGY
RNS Number : 9885G
Allergy Therapeutics PLC
25 November 2015
25 November 2015
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Grant of Options under Long Term Incentive Plan
Allergy Therapeutics plc confirms that certain performance
conditions attaching to provisional awards ("Awards") made pursuant
to the Company's Long Term Incentive Plan ("LTIP") for the three
years ended 30 June 2015, details of which were announced on 19
December 2012, have been met. Consequently, Allergy Therapeutics
has today granted certain of its directors nil cost options
("Options") over the Company's ordinary shares of 0.1 pence each
("Ordinary Shares") in replacement for the Awards made under the
LTIP as follows:
Director Number of Ordinary Total number Total remaining
Shares over of Ordinary Shares number of Ordinary
which Options over which Options Shares provisionally
granted granted awarded under
LTIPs
Manuel Llobet,
Chief Executive Officer 624,024 624,024 2,595,000
Ian Postlethwaite,
Finance Director 312,012 475,512 1,297,500
The Options have been granted in accordance with the LTIP rules
and can be exercisable at nil cost between 25 December 2015 and 25
December 2018.
For further information:
+44 (0) 1903
Allergy Therapeutics 845 820
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
+44 (0) 20 7886
Panmure Gordon 2500
Freddy Crossley / Peter Steel / Duncan Monteith,
Corporate Finance
Tom Salvesen, Corporate Broking
+44 (0) 20 3727
FTI Consulting 1000
Simon Conway
Victoria Foster Mitchell
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company
focused on allergy vaccination. It has a growing business achieving
revenue in the last financial year of GBP43 million mainly in
Europe through its own sales and marketing infrastructure and
further afield through distributors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSZMMZMNKRGKZM
(END) Dow Jones Newswires
November 25, 2015 13:07 ET (18:07 GMT)
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024